New device trial aims to stop deadly brain bleeds
NCT ID NCT04391803
Summary
This study tested a new medical device called the Pipeline Shield to treat people with recently ruptured brain aneurysms who couldn't have standard surgery. The device is placed inside the blood vessel to block blood flow to the aneurysm and prevent re-bleeding. The trial was terminated early and enrolled 25 adults with specific types of aneurysms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACRANIAL ANEURYSM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Geisinger Medical Center
Danville, Pennsylvania, 17822, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Semmes Murphey Clinic
Memphis, Tennessee, 38120, United States
-
Stony Brook University Hospital
Stony Brook, New York, 11794, United States
-
University of Kentucky Albert B Chandler Hospital
Lexington, Kentucky, 40506, United States
-
Wellstar Kennestone Hospital
Marietta, Georgia, 30060, United States
-
Yale New Haven Hospital
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.